Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 130, 2024 - Issue 1
366
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Phoenixin-14 protects cardiac damages in a streptozotocin-induced diabetes mice model through SIRT3

, , , &
Pages 110-118 | Received 18 Jun 2021, Accepted 13 Sep 2021, Published online: 07 Oct 2021

References

  • Al-Rasheed, N.M., et al., 2017. Simvastatin ameliorates diabetic cardiomyopathy by attenuating oxidative stress and inflammation in rats. Oxidative medicine and cellular longevity, 2017, 1092015.
  • Balta, N., et al., 1995. Influence of isoproterenol-induced cardiac hypertrophy on oxidative myocardial stress. Romanian journal of physiology: physiological sciences, 32, 149–154.
  • Bell, J.P., et al., 2001. Vitamin C and quinapril abrogate LVH and endothelial dysfunction in aortic-banded guinea pigs. American journal of physiology. Heart and circulatory physiology, 281 (4), H1704–H1710.
  • Bernardo, B.C., et al., 2010. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacology & therapeutics, 128 (1), 191–227.
  • Christ-Crain, M., et al., 2019. Diabetes insipidus. Nature reviews. Disease primers, 5 (1), 54.
  • Dikalova, A.E., et al., 2020. Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circulation research, 126 (4), 439–452.
  • Eckel, R.H., Barouch, W.W., and Ershow, A.G., 2002. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation, 105 (24), 2923–2928.
  • Feuerstein, G., et al., 1998. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Progress in cardiovascular diseases, 41 (1 Suppl 1), 17–24.
  • Fitzwalter, B.E. and Thorburn, A., 2018. FOXO3 links autophagy to apoptosis. Autophagy, 14 (8), 1467–1468.
  • Frey, N. and Olson, E.N., 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annual review of physiology, 65, 45–79.
  • Han, R.W., et al., 2013. Neuropeptide S enhances memory and mitigates memory impairment induced by MK801, scopolamine or Aβ₁₋₄₂ in mice novel object and object location recognition tasks. Neuropharmacology, 70, 261–267.
  • Huynh, K., et al., 2010. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes, 59 (6), 1512–1520.
  • Huynh, K., et al., 2013. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice. Free radical biology & medicine, 60, 307–317.
  • Jia, G., Hill, M.A., and Sowers, J.R., 2018. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circulation research, 122 (4), 624–638.
  • Julius, D. and Basbaum, A.I., 2001. Molecular mechanisms of nociception. Nature, 413 (6852), 203–210.
  • Katwal, G., et al., 2018. SIRT3 a major player in attenuation of hepatic ischemia-reperfusion injury by reducing ROS via its downstream mediators: SOD2, CYP-D, and HIF-1α. Oxidative medicine and cellular longevity, 2018, 2976957.
  • Liu, Y., et al., 2015. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice. Cellular physiology and biochemistry, 35 (5), 1975–1985.
  • Luo, B., et al., 2017. NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy. Frontiers in physiology, 8, 519.
  • Lyu, R.M., et al., 2013. Phoenixin: a novel peptide in rodent sensory ganglia. Neuroscience, 250, 622–631.
  • Ma, H., et al., 2020. Phoenixin 14 inhibits ischemia/reperfusion-induced cytotoxicity in microglia. Archives of biochemistry and biophysics, 689, 108411.
  • Mizamtsidi, M., et al., 2016. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? European journal of clinical investigation, 46 (11), 947–953.
  • Moraes-Silva, I.C., et al., 2010. Baroreflex deficit blunts exercise training-induced cardiovascular and autonomic adaptations in hypertensive rats. Clinical and experimental pharmacology & physiology, 37 (3), e114–e120.
  • Nakamura, K., et al., 1998. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin II. Circulation, 98 (8), 794–799.
  • Qi, X., et al., 2020. Diurnal rhythmicity of autophagy is impaired in the diabetic retina. Cells, 9 (4), 905.
  • Reda, H.M., Zaitone, S.A., and Moustafa, Y.M., 2016. Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: influence on spinal microglia and astrocytes. European journal of pharmacology, 771, 162–172.
  • Ritchie, R.H., et al., 2012. Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes. Diabetologia, 55 (12), 3369–3381.
  • Sawyer, D.B., et al., 2002. Role of oxidative stress in myocardial hypertrophy and failure. Journal of molecular and cellular cardiology, 34 (4), 379–388.
  • Schlienger, J.L., 2013. Type 2 diabetes complications. Presse medicale (Paris, France : 1983), 42 (5), 839–848.
  • Sierra, A.P.R., et al., 2019. Angiotensin-converting enzyme related-polymorphisms on inflammation, muscle and myocardial damage after a marathon race. Frontiers in genetics, 10, 984.
  • Skulachev, V.P., 1996. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Quarterly reviews of biophysics, 29 (2), 169–202.
  • Spencer, N.Y., et al., 2018. Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes. PLoS One, 13 (7), e0200249.
  • Tseng, A.H., Shieh, S.S., and Wang, D.L., 2013. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free radical biology & medicine, 63, 222–234.
  • Tseng, A.H., et al., 2014. SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia. The biochemical journal, 464 (1), 157–168.
  • Uday, G., et al., 2007. LHRH antagonist attenuates the effect of fluoxetine on marble-burying behavior in mice. European journal of pharmacology, 563 (1–3), 155–159.
  • Wichi, R., et al., 2007. Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents. Cardiovascular diabetology, 6 (1), 14.
  • Xie, Z., et al., 1999. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. The journal of biological chemistry, 274 (27), 19323–19328.
  • Yan, H., et al., 2012. Effects of glutamine treatment on myocardial damage and cardiac function in rats after severe burn injury. International journal of clinical and experimental pathology, 5 (7), 651–659.
  • Yi, X., et al., 2019. SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo. Theranostics, 9 (6), 1614–1633.
  • Yosten, G.L., et al., 2013. A novel reproductive peptide, phoenixin. Journal of neuroendocrinology, 25 (2), 206–215.
  • Zhang, Y., Chen, W., and Wang, Y., 2020. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 125, 110022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.